-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In March 2022, the team of Professor Ma Lulin from the Department of Urology of Peking University Third Hospital and the team of Professor Ci Weimin from Beijing Institute of Genomics, Chinese Academy of Sciences (National Center for Bioinformatics) will be ranked in the field of Biotechnology & Applied Microbiolo.
Renal cancer with tumor thrombus growth is one of the malignant features of renal canc.
In response to this problem, led by Professor Ma Lulin, through the cooperation of the two teams, more than 120,000 cells were collected from adjacent clear cell carcinoma, primary tumor and tumor thrombus tiss.
This study provides a potential therapeutic pathway and target for the treatment of advanced renal cancer and the reduction of tumor thrombus by panoramically depicting the tumor microenvironment differences between the primary tumor and tumor thrombus of renal clear cell carcino.
Bi Hai, deputy chief physician of the Department of Urology, Peking University Third Hospital, Lu Min, associate professor of the Department of Pathology, Shi Yue, associate researcher and doctoral student Zhang Qi of the Key Laboratory of Precision Genome Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences (National Center for Bioinformatics), are the co-authors of the artic.
